rs368299537
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001614.5(ACTG1):c.168C>T(p.Asp56Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000446 in 1,613,778 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001614.5 synonymous
Scores
Clinical Significance
Conservation
Publications
- Baraitser-winter syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
- nonsyndromic genetic hearing lossInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- autosomal dominant nonsyndromic hearing loss 20Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Baraitser-Winter cerebrofrontofacial syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -17 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ACTG1 | NM_001614.5 | c.168C>T | p.Asp56Asp | synonymous_variant | Exon 3 of 6 | ENST00000573283.7 | NP_001605.1 | |
| ACTG1 | NM_001199954.3 | c.168C>T | p.Asp56Asp | synonymous_variant | Exon 3 of 6 | NP_001186883.1 | ||
| ACTG1 | NR_037688.3 | n.240C>T | non_coding_transcript_exon_variant | Exon 3 of 7 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152138Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000518 AC: 13AN: 250878 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.0000411 AC: 60AN: 1461522Hom.: 0 Cov.: 37 AF XY: 0.0000454 AC XY: 33AN XY: 727066 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152256Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74442 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:1
p.Asp56Asp in exon 3 of ACTG1: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 17/276748 chromosom es by the Genome Aggregation Consortium (gnomAD, http://gnomad.broadinstitute.or g; dbSNP rs368299537). -
ACTG1-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Autosomal dominant nonsyndromic hearing loss 20;C3281235:Baraitser-winter syndrome 2 Benign:1
- -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at